世界のペプチド治療薬市場2023-2030:用途別、種類別(ジェネリック、革新的)、メーカー種類別、投与経路別、合成技術別、地域別

【英語タイトル】Peptide Therapeutics Market Size, Share & Trends Analysis Report By Application, By Type (Generic, Innovative), By Type Of Manufacturer, By Route Of Administration, By Synthesis Technology, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23JUN085)・商品コード:GRV23JUN085
・発行会社(調査会社):Grand View Research
・発行日:2023年5月9日
・ページ数:110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界のペプチド治療薬市場規模が、予測期間中(2023年~2030年)に年平均6.3%増加し、2030年までに688.7億ドルへ達すると見込まれています。本調査書では、ペプチド治療薬の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、用途別(がん、代謝疾患、循環器疾患、皮膚疾患、その他)分析、種類別(ジェネリック、革新的)分析、メーカー種類別(インハウス、アウトソーシング)分析、投与経路別(非経口、経口、経肺、経粘膜、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋中南米、中東・アフリカ)分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、Eli Lilly and Company、Pfizer, Inc.、Amgen, Inc.、Takeda Pharmaceutical Company Limited、AstraZeneca、Teva Pharmaceutical Industries Ltd.、Sanofi、F. Hoffmann-La Roche Ltd、Novartis AG、Novo Nordisk A/S、GSK plcなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界ペプチド治療薬の市場規模:用途別
- がんにおける市場規模
- 代謝疾患における市場規模
- 循環器疾患における市場規模
- 皮膚疾患における市場規模
- その他用途における市場規模
・世界ペプチド治療薬の市場規模:種類別
- ジェネリックペプチド治療薬の市場規模
- 革新的ペプチド治療薬の市場規模
・世界ペプチド治療薬の市場規模:メーカー種類別
- インハウスにおける市場規模
- アウトソーシングにおける市場規模
・世界ペプチド治療薬の市場規模:投与経路別
- 非経口投与における市場規模
- 経口投与における市場規模
- 経肺投与における市場規模
- 経粘膜投与における市場規模
- その他投与における市場規模
・世界ペプチド治療薬の市場規模:地域別
- 北米のペプチド治療薬市場規模
- ヨーロッパのペプチド治療薬市場規模
- アジア太平洋のペプチド治療薬市場規模
- 中南米のペプチド治療薬市場規模
- 中東・アフリカのペプチド治療薬市場規模
・競争状況

ペプチド治療薬市場の成長と動向

Grand View Research社の最新レポートによると、世界のペプチド治療薬市場規模は2030年までに688億7000万米ドルに達し、2023年から2030年までCAGR 6.3%で成長する見込みです。癌やその他の生活習慣病の治療のために副作用の少ない効率的で即効性のある治療薬への需要が高まり、それが市場成長を促進すると予測されています。癌の罹患率が上昇していることから、他の治療法や低コストの治療法の模索と導入が求められており、市場の牽引役となることが予想されます。さらに、高齢者人口の増加は、癌や糖尿病などの対象疾患の罹患率を誘発することにより、消費者基盤を拡大すると予想され、ペプチド治療薬の需要を促進すると期待されています。

国際がん研究機関(GLOBOCAN 2020)の報告書によると、2020年に新たに診断されるがん患者は世界で19,292,789人となり、がんによる死亡者数は9,958,133人となります。さらに、がんの5年間の有病率は世界で50,550,287人になると予測されました。2040年には、世界の新規がん患者数は28,887,940人に達すると予測されています。その結果、世界中で癌の発生率が高くなることは、予測期間中、ペプチド治療薬の開発に重要な役割を果たすことになります。それに加えて、化学療法や放射線療法の悪影響に対する医療提供者や患者の意識の高まりが、ペプチドベースの薬剤のような代替治療への重点の高まりに影響を与える主な要因となっています。

ペプチド製造プロセスにおける技術的進歩が、予測期間中の市場を牽引しています。メーカーやサプライヤーは、少ない時間と資本投資で効率的な薬剤分子を製造するための新技術の採用に注力しています。精製や自動化プロセスの改善、廃棄物の発生が少ないことも、市場成長のさらなる要因となっています。例えば、Amgen社は2022年3月、ノースカロライナ州ホリースプリングスに最新のバイオ製造施設を正式に開設すると発表しました。2025年に開設予定のこの施設は、がんや心臓病といった深刻な病気を治療するAmgenの医薬品の成長に対応するのに役立つとみられています。

COVID-19の大流行は、診断の遅れ、治療介入、がん治療のための費用対効果の高い治療薬の開発に焦点を当てた臨床試験の阻害など、がん治療のスペクトラムに拍車をかけると予想されており、がん治療のためのペプチド治療薬も例外ではない、と『Nature Cancer』誌2020年版に掲載された研究論文は述べています。急性呼吸窮迫症候群(ARDS)や重症急性呼吸器感染症によって引き起こされる他の呼吸器疾患の治療のための15の合成ペプチドなど、2020年5月現在、COVID-19の治療のための21のペプチド医薬品があります。しかし、現在、がんや代謝性疾患などの分野でのペプチド治療薬の実用化においては、薬剤不足や運用上の問題、COVID-19以外の治療薬の臨床試験の遅れなどが足かせとなっています。

例えば、2022年5月、EVER Pharma社は、Bortezomibが症候性骨髄腫およびマントル細胞リンパ腫の治療薬としてEU全域で承認を取得したと発表しました。2022年5月、欧州委員会は、急性および慢性移植片対宿主病に対するNovartisのJakaviポストステロイド療法を承認しました。Jakaviは、欧州でステロイド抵抗性の移植片対宿主病患者に対して広く使用できる最初のJAK1/2阻害剤となります。2021年9月、Nimble Therapeutics社とIncyte社は、さらなる新規ペプチド治療薬を発見するための戦略的共同研究を開始しました。

ペプチド治療薬市場レポートハイライト

– 用途別では、従来の治療法よりも代替治療法の需要が高まっていることから、2022年には癌が第2位の売上シェアを占めました。ペプチドはがん治療における潜在的な治療薬として使用されています。

– ジェネリック医薬品は、ブロックバスターペプチドの特許切れや、ジェネリック医薬品の導入に関する政府の積極的な取り組みにより、売上高が増加すると予想されます。

– 製造業者のタイプ別では、複雑な手順が要求され、製造コストの削減に役立つアウトソーシングへの嗜好の変化により、アウトソーシング・セグメントは予測期間中6.6%の有利なCAGRで拡大するとみられています。

– 合成技術別では、ハイブリッド技術が予測期間中に最も急成長する見込みです。固相と液相の両方のペプチド合成における時間の節約や使いやすさなど、この技術に関連する利点が成長を確証する主な要因です。

– 北米は、ゲノミクスおよびプロテオミクス製品に関する認知度の高さ、確立された研究開発インフラ、資金調達イニシアチブの高まりにより、2022年の売上高で最大のシェアを占めました。

– アジア太平洋地域は、予測期間中に8.7%の有利な成長率を記録すると予想されます。この地域には確立されたジェネリック医薬品産業とAPIプロバイダーが存在し、一部の国では経済が安定しつつあることも相まって、市場の成長を促進すると予測されます。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased database
1.4.2 GVR’s internal database
1.4.3 Secondary sources
1.4.4 Primary research
1.4.5 Details of primary research
1.5 Information or Data Analysis
1.5.1 Data analysis models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity flow analysis
1.7.1.1 Approach 1: Commodity flow approach
1.7.1.2 Approach 2: Country wise market estimation using bottom up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
1.12 List of Tables
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Regulatory and Reimbursement Framework
3.2 Market Variable Analysis
3.2.1 Increasing incidence of cancer
3.2.2 Rising prevalence of metabolic disorders
3.2.3 Presence of strong product pipeline
3.2.4 Technological advancement
3.3 Market Restraint Analysis
3.3.1 Increasing complexity of peptides
3.3.2 High cost of manufacturing equipment
3.4 Penetration and Growth Prospect Mapping
3.5 Peptide Therapeutics Market Analysis Tools
3.5.1 Porter’s five forces analysis
3.5.2 SWOT analysis; by factor (Political & Legal, Economic and Technological)
3.5.3 Major deals & strategic alliances analysis
3.5.3.1 New product launch
3.5.3.2 Mergers and acquisitions
3.5.3.3 Expansion
3.5.3.4 Partnerships
3.5.3.5 Marketing & promotions
3.5.3.6 Market entry strategies
Chapter 4 Application Movement Analysis
4.1 Peptide Therapeutics Market: Application Movement Analysis
4.2 Cancer
4.2.1 Cancer market estimates and forecast, 2018 – 2030 (USD Billion)
4.3 Metabolic Disorders
4.3.1 Metabolic disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.4 Cardiovascular Disorders
4.4.1 Cardiovascular disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.5 Dermatological Disorders
4.5.1 Dermatological disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.6 Infectious Diseases
4.6.1 Infectious diseases market estimates and forecast, 2018 – 2030 (USD Billion)
4.7 Neurological Disorders
4.7.1 Neurological disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.8 Gastrointestinal Disorders
4.8.1 Gastrointestinal disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.9 Renal Disorders
4.9.1 Renal disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.10 Respiratory Disorders
4.10.1 Respiratory disorders market estimates and forecast, 2018 – 2030 (USD Billion)
4.11 Pain
4.11.1 Pain market estimates and forecast, 2018 – 2030 (USD Billion)
4.12 Others
4.12.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 5 Type Movement Analysis
5.1 Peptide therapeutics Market: Type Movement Analysis
5.2 Generic
5.2.1 Generic market estimates and forecast, 2018 – 2030 (USD Billion)
5.3 Innovative
5.3.1 Innovative market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 6 Type of Manufacturers Movement Analysis
6.1 Peptide Therapeutics Market: Type of Manufacturers Movement Analysis
6.2 In-house
6.2.1 In-house market estimates and forecast, 2018 – 2030 (USD Billion)
6.3 Outsourced
6.3.1 Outsourced market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 7 Route of Administration Movement Analysis
7.1 Peptide Therapeutics Market: Route of Administration Movement Analysis
7.2 Parenteral
7.2.1 Parenteral market estimates and forecast, 2018 – 2030 (USD Billion)
7.3 Oral
7.3.1 Oral market estimates and forecast, 2018 – 2030 (USD Billion)
7.4 Pulmonary
7.4.1 Pulmonary market estimates and forecast, 2018 – 2030 (USD Billion)
7.5 Mucosal
7.5.1 Mucosal market estimates and forecast, 2018 – 2030 (USD Billion)
7.6 Others
7.6.1 Others market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 8 Synthesis Technology Movement Analysis
8.1 Peptide Therapeutics Market: Synthesis Technology Movement Analysis
8.2 Solid Phase Peptide Synthesis (SPPS)
8.2.1 SPPS market estimates and forecast, 2018 – 2030 (USD Billion)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.3.1 LPPS market estimates and forecast, 2018 – 2030 (USD Billion)
8.4 Hybrid
8.4.1 Hybrid market estimates and forecast, 2018 – 2030 (USD Billion)
Chapter 9 Regional Business Analysis
9.1 Peptide Therapeutics Market: Regional Outlook
9.2 North America
9.2.1 North America Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 U.S. Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.2.2.3 Target Disease Prevalence
9.2.2.5 Competitive Scenario
9.2.2.6 Regulatory Framework
9.2.2.7 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Canada Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.2.3.3 Target Disease Prevalence
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.3.2 U.K.
9.3.2.1 Key Country Dynamics
9.3.2.2 U.K. Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.2.3 Target Disease Prevalence
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Germany Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.3.3 Target Disease Prevalence
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 France Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.4.3 Target Disease Prevalence
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Italy
9.3.5.1 Key Country Dynamics
9.3.5.2 Italy Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.5.3 Target Disease Prevalence
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Spain
9.3.6.1 Key Country Dynamics
9.3.6.2 Spain Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.6.3 Target Disease Prevalence
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.9.1 Key Country Dynamics
9.3.9.2 Denmark Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Sweden Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.8.3 Target Disease Prevalence
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Norway Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.4 Asia Pacific
9.4.1 Asia Pacific Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Japan Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.2.3 Target Disease Prevalence
9.4.2.4 Competitive Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 China Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.3.3 Target Disease Prevalence
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 India Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.4.3 Target Disease Prevalence
9.4.4.4 Competitive Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Australia Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.5.3 Target Disease Prevalence
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 South Korea
9.4.6.1 Key Country Dynamics
9.4.6.2 South Korea Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.6.3 Target Disease Prevalence
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Thailand Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.4.7.3 Target Disease Prevalence
9.4.7.4 Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.5 Latin America
9.5.1 Latin America Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Mexico Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.3.3 Target Disease Prevalence
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Argentina Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.4.3 Target Disease Prevalence
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.4 Chile
9.5.5.1 Key Country Dynamics
9.5.5.2 Chile Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.5.5.3 Target Disease Prevalence
9.5.5.4 Competitive Scenario
9.5.5.5 Regulatory Framework
9.5.5.6 Reimbursement Scenario
9.6 Middle East and Africa
9.6.1 Middle East and Africa Peptide Therapeutics Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
9.6.1.1 Target Disease Prevalence
9.6.1.2 Competitive Scenario
9.6.1.3 Regulatory Framework
9.6.1.4 Reimbursement Scenario
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 South Africa Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.2.3 Target Disease Prevalence
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Saudi Arabia Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.3.3 Target Disease Prevalence
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 UAE Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.4.3 Target Disease Prevalence
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Kuwait Peptide Therapeutics Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Billion)
9.6.5.3 Target Disease Prevalence
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 Eli Lilly and Company
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 Pfizer, Inc.
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 Amgen, Inc.
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Takeda Pharmaceutical Company Limited
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 AstraZeneca
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 Teva Pharmaceutical Industries Ltd.
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 Sanofi
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 F. Hoffmann-La Roche Ltd
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Novartis AG
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 Novo Nordisk A/S
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
10.4.11 GSK plc
10.4.11.1 Company Overview
10.4.11.2 Financial Performance
10.4.11.3 Product Benchmarking
10.4.11.4 Strategic Initiatives
10.4.12 Ironwood Pharmaceuticals, Inc.
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Radius Health, Inc.
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
10.4.14 Ipsen Pharma
10.4.14.1 Company Overview
10.4.14.2 Financial Performance
10.4.14.3 Product Benchmarking
10.4.14.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 4 North America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 5 North America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 6 North America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 7 North America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 8 North America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 9 U.S. peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 10 U.S. peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 11 U.S. peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 12 U.S. peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 13 U.S. peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 14 Canada peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 15 Canada peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 16 Canada peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 17 Canada peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 18 Canada peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 19 Europe peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 20 Europe peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 21 Europe peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 22 Europe peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 23 Europe peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 24 Europe peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 25 UK peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 26 UK peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 27 UK peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 28 UK peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 29 UK peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 30 Germany peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 31 Germany peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 32 Germany peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 33 Germany peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 34 Germany peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 35 France peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 36 France peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 37 France peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 38 France peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 39 France peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 40 Spain peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 41 Spain peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 42 Spain peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 43 Spain peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 44 Spain peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 45 Italy peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 46 Italy peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 47 Italy peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 48 Italy peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 49 Italy peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 49 Denmark peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 50 Denmark peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 51 Denmark peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 52 Denmark peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 53 Denmark peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 54 Sweden peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 55 Sweden peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 56 Sweden peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 57 Sweden peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 58 Sweden peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 59 Norway peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 60 Norway peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 61 Norway peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 62 Norway peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 63 Norway peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 64 Asia Pacific peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 65 Asia Pacific peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 66 Asia Pacific peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 67 Asia Pacific peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 68 Asia Pacific peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 69 Asia Pacific peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 70 Japan peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 71 Japan peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 72 Japan peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 73 Japan peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 74 Japan peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 75 China peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 76 China peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 77 China peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 78 China peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 79 China peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 80 India peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 81 India peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 82 India peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 83 India peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 84 India peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 85 South Korea peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 86 South Korea peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 87 South Korea peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 88 South Korea peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 89 South Korea peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 90 Australia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 91 Australia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 92 Australia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 93 Australia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 94 Australia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 95 Thailand peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 96 Thailand peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 97 Thailand peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 98 Thailand peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 99 Thailand peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 100 Latin America peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 102 Latin America peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 102 Latin America peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 103 Latin America peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 104 Latin America peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 105 Latin America peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 106 Brazil peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 107 Brazil peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 108 Brazil peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 109 Brazil peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 110 Brazil peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 111 Mexico peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 112 Mexico peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 113 Mexico peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 114 Mexico peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 115 Mexico peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 116 Argentina peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 117 Argentina peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 118 Argentina peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 119 Argentina peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 120 Argentina peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 121 Chile peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 122 Chile peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 123 Chile peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 124 Chile peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 125 Chile peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 126 MEA peptide therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Billion)
Table 127 MEA peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 128 MEA peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 129 MEA peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 130 MEA peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 131 MEA peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 132 South Africa peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 133 South Africa peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 134 South Africa peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 135 South Africa peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 136 South Africa peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 137 UAE peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 138 UAE peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 139 UAE peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 140 UAE peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 141 UAE peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 143 Saudi Arabia peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 144 Saudi Arabia peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 145 Saudi Arabia peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 146 Saudi Arabia peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)
Table 147 Kuwait peptide therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Billion)
Table 148 Kuwait peptide therapeutics market estimates and forecasts, by type, 2018 - 2030 (USD Billion)
Table 149 Kuwait peptide therapeutics market estimates and forecasts, by type of manufacturers, 2018 - 2030 (USD Billion)
Table 150 Kuwait peptide therapeutics market estimates and forecasts, by route of administration, 2018 - 2030 (USD Billion)
Table 151 Kuwait peptide therapeutics market estimates and forecasts, by synthesis technology, 2018 - 2030 (USD Billion)

★調査レポート[世界のペプチド治療薬市場2023-2030:用途別、種類別(ジェネリック、革新的)、メーカー種類別、投与経路別、合成技術別、地域別] (コード:GRV23JUN085)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペプチド治療薬市場2023-2030:用途別、種類別(ジェネリック、革新的)、メーカー種類別、投与経路別、合成技術別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆